Staring down IP theft lawsuit, synthetic biology company seeks $86M IPO

Twist Biosciences Corp. — a fast-growing company that makes synthetic DNA modified to serve as a tool in drug research and development, industrial chemicals, agriculture and even data storage — filed Wednesday to raise $86.3 million through an initial public offering. Twist, based in San Francisco but moving next year to space in South San Francisco, is the 18th Bay Area life sciences company to file or complete an IPO this year. It is the most biotech IPOs in a calendar year since 19 companies…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news